Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1

[1]  M. Keshavan,et al.  Precision medicine for psychosis: a revolution at the interface of psychiatry and neurology , 2023, Nature Reviews Neurology.

[2]  B. Clementz.  The Carpenter-Strauss Quest to Save Schizophrenia: How DSM Shifted the Construct From Its Historical Core , 2023, Biomarkers in Neuropsychiatry.

[3]  B. Clementz.  Psychosis and fever revisited , 2021, Schizophrenia Research.

[4]  G. Pearlson,et al.  Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium , 2021, Schizophrenia bulletin.

[5]  G. Pearlson,et al.  Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. , 2021, The American journal of psychiatry.

[6]  Gabriel A. Devenyi,et al.  A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study. , 2021, Schizophrenia bulletin.

[7]  R. Gibbons,et al.  Development of a computerized adaptive diagnostic screening tool for psychosis , 2021, Schizophrenia Research.

[8]  G. Pearlson,et al.  Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2) , 2021, Psychological Medicine.

[9]  D. Kupfer,et al.  Dr. Gibbons et al. Reply. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  G. Pearlson,et al.  White matter microstructure across brain-based biotypes for psychosis – findings from the bipolar-schizophrenia network for intermediate phenotypes , 2020, Psychiatry Research: Neuroimaging.

[11]  D. Kupfer,et al.  Computerized Adaptive Tests for Rapid and Accurate Assessment of Psychopathology Dimensions in Youth. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

[12]  Godfrey Pearlson,et al.  Biotyping in psychosis: using multiple computational approaches with one data set , 2020, Neuropsychopharmacology.

[13]  G. Pearlson,et al.  Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder , 2020, Schizophrenia Research.

[14]  G. Pearlson,et al.  Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features , 2020, Biomarkers in neuropsychiatry.

[15]  G. Pearlson,et al.  Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. , 2020, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[16]  E. Baca-García,et al.  Development of a computerized adaptive substance use disorder scale for screening and measurement: the CAT-SUD. , 2020, Addiction.

[17]  G. Pearlson,et al.  Associating Psychotic Symptoms with Altered Brain Anatomy in Psychotic Disorders Using Multidimensional Item Response Theory Models. , 2019, Cerebral cortex.

[18]  G. Pearlson,et al.  Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. , 2019, Biomarkers in neuropsychiatry.

[19]  J. Strauss,et al.  Ideology and Scientific Progress: First-Rank Symptoms. , 2019, Schizophrenia bulletin.

[20]  Lauren E. Ethridge,et al.  Psychosis subgroups differ in intrinsic neural activity but not task-specific processing , 2017, Schizophrenia Research.

[21]  Lauren E. Ethridge,et al.  Intrinsic neural activity differences among psychotic illnesses. , 2017, Psychophysiology.

[22]  G. Pearlson,et al.  Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes , 2017, Biological Psychiatry.

[23]  C. Fernyhough,et al.  Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes , 2016, Schizophrenia bulletin.

[24]  Lauren E. Ethridge,et al.  Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. , 2016, The American journal of psychiatry.

[25]  Lauren E. Ethridge,et al.  Event-Related Potential and Time-Frequency Endophenotypes for Schizophrenia and Psychotic Bipolar Disorder , 2015, Biological Psychiatry.

[26]  Lauren E. Ethridge,et al.  Behavioral response inhibition in psychotic disorders: Diagnostic specificity, familiality and relation to generalized cognitive deficit , 2014, Schizophrenia Research.

[27]  Godfrey D Pearlson,et al.  Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. , 2014, Schizophrenia bulletin.

[28]  Lauren E. Ethridge,et al.  Diagnostic specificity and familiality of early versus late evoked potentials to auditory paired stimuli across the schizophrenia-bipolar psychosis spectrum. , 2014, Psychophysiology.

[29]  Godfrey D Pearlson,et al.  Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. , 2013, The American journal of psychiatry.

[30]  G. Pearlson,et al.  Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). , 2013, The American journal of psychiatry.

[31]  N. Craddock,et al.  DSM-5 and RDoC: progress in psychiatry research? , 2013, Nature Reviews Neuroscience.

[32]  W. Carpenter.  The psychoses in DSM-5 and in the near future. , 2013, The American journal of psychiatry.

[33]  Giles Hooker,et al.  The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression. , 2013, The Journal of clinical psychiatry.

[34]  Steven E. Hyman,et al.  Revolution Stalled , 2012, Science Translational Medicine.

[35]  A. Jablensky.  The nosological entity in psychiatry: a historical illusion or a moving target? , 2012 .

[36]  K. Kendler.  Epistemic iteration as a historical model for psychiatric nosology: promises and limitations , 2012 .

[37]  M. Keshavan,et al.  Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse , 2011, Schizophrenia Research.

[38]  Russell Schachar,et al.  Inhibitory control and psychopathology: A meta-analysis of studies using the stop signal task , 2010, Journal of the International Neuropsychological Society.

[39]  S. Hyman,et al.  The diagnosis of mental disorders: the problem of reification. , 2010, Annual review of clinical psychology.

[40]  W. Carpenter,et al.  Will The Kraepelinian Dichotomy Survive DSM-V? , 2009, Neuropsychopharmacology.

[41]  Philip D. Harvey,et al.  Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) , 2008, Schizophrenia Research.

[42]  John A. Sweeney,et al.  Reduced Attentional Engagement Contributes to Deficits in Prefrontal Inhibitory Control in Schizophrenia , 2008, Biological Psychiatry.

[43]  J. Polich.  Updating P300: An integrative theory of P3a and P3b , 2007, Clinical Neurophysiology.

[44]  Pierre Geurts,et al.  Extremely randomized trees , 2006, Machine Learning.

[45]  D. Linden.  The P300: Where in the Brain Is It Produced and What Does It Tell Us? , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[46]  Chris H. Q. Ding,et al.  K-means clustering via principal component analysis , 2004, ICML.

[47]  Philip D. Harvey,et al.  The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery , 2004, Schizophrenia Research.

[48]  Jennifer E. McDowell,et al.  Behavioral and brain imaging studies of saccadic performance in schizophrenia , 2001, Biological Psychology.

[49]  C. Lançon,et al.  Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS) , 2000, Schizophrenia Research.

[50]  M. Birchwood,et al.  The Social Functioning Scale the Development and Validation of a New Scale of Social Adjustment for use in Family Intervention Programmes with Schizophrenic Patients , 1990, British Journal of Psychiatry.

[51]  R Freedman,et al.  Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. , 1982, Biological psychiatry.

[52]  P. E. Hallett,et al.  The predictability of saccadic latency in a novel voluntary oculomotor task , 1980, Vision Research.

[53]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[54]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[55]  P. Meehl.  Theoretical risks and tabular asterisks: Sir Karl, Sir Ronald, and the slow progress of soft psychology. , 1978 .

[56]  J. Strauss,et al.  The diagnosis and understanding of schizophrenia. Part I. Use of signs and symptoms for the identification of schizophrenic patients. , 1974, Schizophrenia bulletin.

[57]  J. Strauss,et al.  Flexible System for the Diagnosis of Schizophrenia: Report from the WHO International Pilot Study of Schizophrenia , 1973, Science.

[58]  Gerome Breen,et al.  Psychiatric Genomics: An Update and an Agenda , 2017, bioRxiv.

[59]  Matcheri Keshavan,et al.  Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes. , 2017, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[60]  L. Breiman.  Random Forests , 2001, Machine Learning.

[61]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[62]  R Freedman,et al.  Neurobiological studies of sensory gating in schizophrenia. , 1987, Schizophrenia bulletin.

[63]  S. Guze,et al.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. , 1970, The American journal of psychiatry.